化学
铜绿假单胞菌
生物膜
生物利用度
微生物学
抗菌剂
药代动力学
体内
细菌
药理学
医学
有机化学
遗传学
生物技术
生物
作者
Roman Sommer,Stefanie Wagner,Katharina Rox,Annabelle Varrot,Dirk Hauck,Eike‐Christian Wamhoff,Janine Schreiber,Thomas Ryckmans,Thomas Brunner,Christoph Rademacher,Rolf W. Hartmann,Mark Brönstrup,Anne Imberty,Alexander Titz
摘要
The opportunistic Gram-negative bacterium Pseudomonas aeruginosa is a leading pathogen for infections of immuno-compromised patients and those suffering from cystic fibrosis. Its ability to switch from planktonic life to aggregates, forming the so-called biofilms, is a front-line mechanism of antimicrobial resistance. The bacterial carbohydrate-binding protein LecB is an integral component and necessary for biofilm formation. Here, we report a new class of drug-like low molecular weight inhibitors of the lectin LecB with nanomolar affinities and excellent receptor binding kinetics and thermodynamics. This class of glycomimetic inhibitors efficiently blocked biofilm formation of P. aeruginosa in vitro while the natural monovalent carbohydrate ligands failed. Furthermore, excellent selectivity and pharmacokinetic properties were achieved. Notably, two compounds showed good oral bioavailability, and high compound concentrations in plasma and urine were achieved in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI